{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T04:15:02Z","timestamp":1742876102036,"version":"3.40.2"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01603-6","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T23:47:45Z","timestamp":1742860065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structured reporting of gliomas based on VASARI criteria to improve report content and consistency"],"prefix":"10.1186","volume":"25","author":[{"given":"Olivia","family":"Goodkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh","family":"Pemberton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferran","family":"Prados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoerd B.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Thust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Yousry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotirios","family":"Bisdas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"1603_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000464374","volume":"30","author":"QT Ostrom","year":"2017","unstructured":"Ostrom QT, Gittleman H, Stetson L, et al. Epidemiology of Intracranial Gliomas. Prog Neurol Surg. 2017;30:1\u201311. https:\/\/doi.org\/10.1159\/000464374.","journal-title":"Prog Neurol Surg"},{"key":"1603_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/NEUONC\/NOAB106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23:1231\u201351. https:\/\/doi.org\/10.1093\/NEUONC\/NOAB106.","journal-title":"Neuro Oncol"},{"key":"1603_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jocn.2021.04.043","volume":"89","author":"QD Buchlak","year":"2021","unstructured":"Buchlak QD, Esmaili N, Leveque JC, et al. Machine learning applications to neuroimaging for glioma detection and classification: An artificial intelligence augmented systematic review. J Clin Neurosci. 2021;89:177\u201398.","journal-title":"J Clin Neurosci"},{"key":"1603_CR4","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/nejmoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med. 2005;352:987\u201396. https:\/\/doi.org\/10.1056\/nejmoa043330.","journal-title":"N Engl J Med"},{"issue":"9","key":"1603_CR5","first-page":"121","volume":"3","author":"RM Young","year":"2015","unstructured":"Young RM, Jamshidi A, Davis G, Sherman JH. Current trends in the surgical management and treatment of adult glioblastoma. Ann Transl Med. 2015;3(9):121.","journal-title":"Ann Transl Med"},{"key":"1603_CR6","doi-asserted-by":"publisher","unstructured":"Fernandes C, Costa A, Os\u00f3rio L, et al. Current Standards of Care in Glioblastoma Therapy. In: De Vleeschouwer S, editor. Glioblastoma [Internet]. Brisbane (AU): Codon Publications; 2017 Sep 27. Chapter 11. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK469987\/, https:\/\/doi.org\/10.15586\/codon.glioblastoma.2017.ch11.","DOI":"10.15586\/codon.glioblastoma.2017.ch11"},{"key":"1603_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/NEUONC\/NOX176","volume":"20","author":"MMJ Wijnenga","year":"2018","unstructured":"Wijnenga MMJ, French PJ, Dubbink HJ, et al. The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis. Neuro Oncol. 2018;20:103\u201312. https:\/\/doi.org\/10.1093\/NEUONC\/NOX176.","journal-title":"Neuro Oncol"},{"key":"1603_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fneur.2018.00032","volume":"9","author":"A Bink","year":"2018","unstructured":"Bink A, Benner J, Reinhardt J, et al. Structured reporting in neuroradiology: Intracranial tumors. Front Neurol. 2018;9:32. https:\/\/doi.org\/10.3389\/fneur.2018.00032.","journal-title":"Front Neurol"},{"issue":"6","key":"1603_CR9","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.acra.2019.07.028","volume":"27","author":"JY Zhang","year":"2019","unstructured":"Zhang JY, Weinberg BD, Hu R, et al. Quantitative Improvement in Brain Tumor MRI Through Structured Reporting (BT-RADS). Acad Radiol. 2019;27(6):780\u20134. https:\/\/doi.org\/10.1016\/j.acra.2019.07.028.","journal-title":"Acad Radiol"},{"key":"1603_CR10","unstructured":"VASARI\u2014Cancer Imaging Program. Available online: https:\/\/wiki.nci.nih.gov\/display\/CIP\/VASARI. Accessed on 04 Mar 2025."},{"key":"1603_CR11","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.3389\/FONC.2020.581037\/BIBTEX","volume":"10","author":"R Meier","year":"2020","unstructured":"Meier R, Pahud de Mortanges A, Wiest R, Knecht U. Exploratory Analysis of Qualitative MR Imaging Features for the Differentiation of Glioblastoma and Brain Metastases. Front Oncol. 2020;10:2756. https:\/\/doi.org\/10.3389\/FONC.2020.581037\/BIBTEX.","journal-title":"Front Oncol"},{"key":"1603_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1148\/RADIOL.13120118","volume":"267","author":"D Gutman","year":"2013","unstructured":"Gutman D, Cooper LA, Hwang SN, et al. MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology. 2013;267:560\u20139. https:\/\/doi.org\/10.1148\/RADIOL.13120118.","journal-title":"Radiology"},{"key":"1603_CR13","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/neuonc\/now256","volume":"19","author":"H Zhou","year":"2017","unstructured":"Zhou H, Valli\u00e8res M, Bai HX, et al. MRI features predict survival and molecular markers in diffuse lower-grade gliomas. Neuro Oncol. 2017;19:862\u201370. https:\/\/doi.org\/10.1093\/neuonc\/now256.","journal-title":"Neuro Oncol"},{"key":"1603_CR14","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/neuonc\/nov117","volume":"17","author":"P Wangaryattawanich","year":"2015","unstructured":"Wangaryattawanich P, Hatami M, Wang J, et al. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Neuro Oncol. 2015;17:1525\u201337. https:\/\/doi.org\/10.1093\/neuonc\/nov117.","journal-title":"Neuro Oncol"},{"key":"1603_CR15","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3174\/AJNR.A2950","volume":"33","author":"JA Carrillo","year":"2012","unstructured":"Carrillo JA, Lai A, Nghiemphu PL, et al. Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation, and Survival in Glioblastoma. Am J Neuroradiol. 2012;33:1349\u201355. https:\/\/doi.org\/10.3174\/AJNR.A2950.","journal-title":"Am J Neuroradiol"},{"key":"1603_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/S10014-018-0321-4\/TABLES\/2","volume":"35","author":"T Yamauchi","year":"2018","unstructured":"Yamauchi T, Ohno M, Matsushita Y, et al. Radiological characteristics based on isocitrate dehydrogenase mutations and 1p\/19q codeletion in grade II and III gliomas. Brain Tumor Pathol. 2018;35:148\u201358. https:\/\/doi.org\/10.1007\/S10014-018-0321-4\/TABLES\/2.","journal-title":"Brain Tumor Pathol"},{"key":"1603_CR17","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/NEUONC\/NOY048","volume":"20","author":"MPG Broen","year":"2018","unstructured":"Broen MPG, Smits M, Wijnenga MMJ, et al. The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p\/19q-intact lower-grade glioma: a validation study. Neuro Oncol. 2018;20:1393\u20139. https:\/\/doi.org\/10.1093\/NEUONC\/NOY048.","journal-title":"Neuro Oncol"},{"key":"1603_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ejrad.2019.03.003","volume":"114","author":"H Hyare","year":"2019","unstructured":"Hyare H, Rice L, Thust S, et al. Modelling MR and clinical features in grade II\/III astrocytomas to predict IDH mutation status. Eur J Radiol. 2019;114:120\u20137. https:\/\/doi.org\/10.1016\/j.ejrad.2019.03.003.","journal-title":"Eur J Radiol"},{"issue":"1","key":"1603_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/S11060-017-2421-0","volume":"133","author":"A Darlix","year":"2017","unstructured":"Darlix A, Deverdun J, de Champfleur NM, et al. IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas. J Neurooncol. 2017;133(1):37\u201345. https:\/\/doi.org\/10.1007\/S11060-017-2421-0.","journal-title":"J Neurooncol."},{"key":"1603_CR20","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.3174\/AJNR.A5171","volume":"38","author":"Z Xing","year":"2017","unstructured":"Xing Z, Yang X, She D, et al. Noninvasive Assessment of IDH Mutational Status in World Health Organization Grade II and III Astrocytomas Using DWI and DSC-PWI Combined with Conventional MR Imaging. Am J Neuroradiol. 2017;38:1138\u201344. https:\/\/doi.org\/10.3174\/AJNR.A5171.","journal-title":"Am J Neuroradiol"},{"key":"1603_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/S10014-014-0211-3\/FIGURES\/3","volume":"32","author":"Y Sonoda","year":"2015","unstructured":"Sonoda Y, Shibahara I, Kawaguchi T, et al. Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas. Brain Tumor Pathol. 2015;32:99\u2013104. https:\/\/doi.org\/10.1007\/S10014-014-0211-3\/FIGURES\/3.","journal-title":"Brain Tumor Pathol"},{"issue":"1","key":"1603_CR22","doi-asserted-by":"publisher","first-page":"vdz001","DOI":"10.1093\/NOAJNL\/VDZ001","volume":"1","author":"MMJ Wijnenga","year":"2019","unstructured":"Wijnenga MMJ, van der Voort SR, French PJ, et al. Differences in spatial distribution between WHO 2016 low-grade glioma molecular subgroups. Neurooncol Adv. 2019;1(1):vdz001. https:\/\/doi.org\/10.1093\/NOAJNL\/VDZ001.","journal-title":"Neurooncol Adv."},{"key":"1603_CR23","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.ijrobp.2018.07.2004","volume":"102","author":"A Berberich","year":"2018","unstructured":"Berberich A, Hielscher T, Kickingereder P, et al. Nonmeasurable Speckled Contrast-Enhancing Lesions Appearing During Course of Disease Are Associated With IDH Mutation in High-Grade Astrocytoma Patients. Int J Radiat Oncol Biol Phys. 2018;102:1472\u201380. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.07.2004.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1603_CR24","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/NEUONC\/NOT235","volume":"16","author":"G Reyes-Botero","year":"2014","unstructured":"Reyes-Botero G, Dehais C, Idbaih A, et al. Contrast enhancement in 1p\/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression. Neuro Oncol. 2014;16:662\u201370. https:\/\/doi.org\/10.1093\/NEUONC\/NOT235.","journal-title":"Neuro Oncol"},{"key":"1603_CR25","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/S00330-015-4025-4\/TABLES\/4","volume":"26","author":"J Xiong","year":"2016","unstructured":"Xiong J, Tan W, Wen J, et al. Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1\/2 mutations but not 1p\/19q genotyping in oligodendroglial tumours. Eur Radiol. 2016;26:1705\u201315. https:\/\/doi.org\/10.1007\/S00330-015-4025-4\/TABLES\/4.","journal-title":"Eur Radiol"},{"key":"1603_CR26","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3174\/AJNR.A4407","volume":"36","author":"YY Wang","year":"2015","unstructured":"Wang YY, Wang K, Li SW, et al. Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation. Am J Neuroradiol. 2015;36:2023\u20139. https:\/\/doi.org\/10.3174\/AJNR.A4407.","journal-title":"Am J Neuroradiol"},{"key":"1603_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.crad.2018.10.002","volume":"74","author":"CQ Su","year":"2019","unstructured":"Su CQ, Lu SS, Zhou MD, et al. Combined texture analysis of diffusion-weighted imaging with conventional MRI for non-invasive assessment of IDH1 mutation in anaplastic gliomas. Clin Radiol. 2019;74:154\u201360. https:\/\/doi.org\/10.1016\/j.crad.2018.10.002.","journal-title":"Clin Radiol"},{"key":"1603_CR28","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.3174\/AJNR.A5794","volume":"39","author":"CC Wu","year":"2018","unstructured":"Wu CC, Jain R, Radmanesh A, et al. Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas. Am J Neuroradiol. 2018;39:1814\u201320. https:\/\/doi.org\/10.3174\/AJNR.A5794.","journal-title":"Am J Neuroradiol"},{"key":"1603_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3174\/AJNR.A4491","volume":"37","author":"K Yamashita","year":"2016","unstructured":"Yamashita K, Hiwatashi A, Togao O, et al. MR Imaging-Based Analysis of Glioblastoma Multiforme: Estimation of IDH1 Mutation Status. Am J Neuroradiol. 2016;37:58\u201365. https:\/\/doi.org\/10.3174\/AJNR.A4491.","journal-title":"Am J Neuroradiol"},{"key":"1603_CR30","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1007\/S00330-018-5400-8\/TABLES\/5","volume":"28","author":"EK Hong","year":"2018","unstructured":"Hong EK, Choi SH, Shin DJ, et al. Radiogenomics correlation between MR imaging features and major genetic profiles in glioblastoma. Eur Radiol. 2018;28:4350\u201361. https:\/\/doi.org\/10.1007\/S00330-018-5400-8\/TABLES\/5.","journal-title":"Eur Radiol"},{"key":"1603_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1148\/radiol.2020191832","volume":"296","author":"J Maynard","year":"2020","unstructured":"Maynard J, Okuchi S, Wastling S, et al. World health organization grade ii\/iii glioma molecular status: Prediction by mri morphologic features and apparent diffusion coefficient. Radiology. 2020;296:111\u201321. https:\/\/doi.org\/10.1148\/radiol.2020191832.","journal-title":"Radiology"},{"key":"1603_CR32","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3171\/2012.7.JNS12147","volume":"117","author":"C Patil","year":"2012","unstructured":"Patil C, Yi A, Elramsisy A, et al. Prognosis of patients with multifocal glioblastoma: a case-control study. J Neurosurg. 2012;117:705\u201311. https:\/\/doi.org\/10.3171\/2012.7.JNS12147.","journal-title":"J Neurosurg"},{"key":"1603_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3174\/AJNR.A5421","volume":"39","author":"Y Park","year":"2018","unstructured":"Park Y, Han K, Ahn SS, et al. Prediction of IDH1-Mutation and 1p\/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas. AJNR Am J Neuroradiol. 2018;39:37\u201342. https:\/\/doi.org\/10.3174\/AJNR.A5421.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1603_CR34","doi-asserted-by":"publisher","unstructured":"Chauhan RS, Kulanthaivelu K, Kathrani N et al. Prediction of H3K27M mutation status of diffuse midline gliomas using MRI features. J Neuroimaging. 2021;31(6):1201\u201310. https:\/\/doi.org\/10.1111\/jon.12905.","DOI":"10.1111\/jon.12905"},{"key":"1603_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00234-020-02532-7","volume":"63","author":"A Lasocki","year":"2020","unstructured":"Lasocki A, Anjari M, \u04e6rs Kokurcan S, Thust SC. Conventional MRI features of adult diffuse glioma molecular subtypes: a systematic review. Neuroradiology. 2020;63:353\u201362. https:\/\/doi.org\/10.1007\/s00234-020-02532-7.","journal-title":"Neuroradiology"},{"key":"1603_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3174\/ajnr.A5421","volume":"39","author":"YWY Park","year":"2018","unstructured":"Park YWY, Han K, Ahn SSS, et al. Prediction of IDH1 -Mutation and 1p\/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas. Am J Neuroradiol. 2018;39:37\u201342. https:\/\/doi.org\/10.3174\/ajnr.A5421.","journal-title":"Am J Neuroradiol"},{"issue":"1","key":"1603_CR37","doi-asserted-by":"publisher","first-page":"e0169292","DOI":"10.1371\/JOURNAL.PONE.0169292","volume":"12","author":"O Eidel","year":"2017","unstructured":"Eidel O, Burth S, Neumann JO, et al. Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology. PLoS One. 2017;12(1):e0169292. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0169292.","journal-title":"PLoS One"},{"key":"1603_CR38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00234-020-02532-7","volume":"63","author":"A Lasocki","year":"2021","unstructured":"Lasocki A, Anjari M, \u04e6rs Kokurcan S, Thust SC. Conventional MRI features of adult diffuse glioma molecular subtypes: a systematic review. Neuroradiology. 2021;63:353\u201362. https:\/\/doi.org\/10.1007\/s00234-020-02532-7.","journal-title":"Neuroradiology"},{"key":"1603_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/J.JNS.2016.12.008","volume":"373","author":"L Zhang","year":"2017","unstructured":"Zhang L, Min Z, Tang M, et al. The utility of diffusion MRI with quantitative ADC measurements for differentiating high-grade from low-grade cerebral gliomas: Evidence from a meta-analysis. J Neurol Sci. 2017;373:9\u201315. https:\/\/doi.org\/10.1016\/J.JNS.2016.12.008.","journal-title":"J Neurol Sci"},{"key":"1603_CR40","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1007\/S00330-018-5351-0\/FIGURES\/5","volume":"28","author":"SC Thust","year":"2018","unstructured":"Thust SC, Hassanein S, Bisdas S, et al. Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II\/III glioma: volumetric segmentation versus two-dimensional region of interest analysis. Eur Radiol. 2018;28:3779\u201388. https:\/\/doi.org\/10.1007\/S00330-018-5351-0\/FIGURES\/5.","journal-title":"Eur Radiol"},{"key":"1603_CR41","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/S11060-014-1490-6\/TABLES\/2","volume":"119","author":"Y Cui","year":"2014","unstructured":"Cui Y, Ma L, Chen X, et al. Lower apparent diffusion coefficients indicate distinct prognosis in low-grade and high-grade glioma. J Neurooncol. 2014;119:377\u201385. https:\/\/doi.org\/10.1007\/S11060-014-1490-6\/TABLES\/2.","journal-title":"J Neurooncol"},{"issue":"6","key":"1603_CR42","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1007\/S00330-020-06683-2","volume":"30","author":"CJ Park","year":"2020","unstructured":"Park CJ, Han K, Shin H, et al. (2020) MR image phenotypes may add prognostic value to clinical features in IDH wild-type lower-grade gliomas. Eur Radiol. 2020;30(6):3035\u201345. https:\/\/doi.org\/10.1007\/S00330-020-06683-2.","journal-title":"Eur Radiol"},{"key":"1603_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11060-016-2278-7","volume":"131","author":"AM Mistry","year":"2017","unstructured":"Mistry AM, Hale AT, Chambless LB, et al. Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis. J Neurooncol. 2017;131:125\u201333. https:\/\/doi.org\/10.1007\/s11060-016-2278-7.","journal-title":"J Neurooncol"},{"key":"1603_CR44","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3389\/FONC.2020.00852","volume":"10","author":"G Shen","year":"2020","unstructured":"Shen G, Wang R, Gao B, et al. The MRI Features and Prognosis of Gliomas Associated With IDH1 Mutation: A Single Center Study in Southwest China. Front Oncol. 2020;10:852. https:\/\/doi.org\/10.3389\/FONC.2020.00852.","journal-title":"Front Oncol."},{"key":"1603_CR45","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/S10143-018-0981-X\/TABLES\/8","volume":"42","author":"T Kanazawa","year":"2019","unstructured":"Kanazawa T, Fujiwara H, Takahashi H, et al. Imaging scoring systems for preoperative molecular diagnoses of lower-grade gliomas. Neurosurg Rev. 2019;42:433\u201341. https:\/\/doi.org\/10.1007\/S10143-018-0981-X\/TABLES\/8.","journal-title":"Neurosurg Rev"},{"key":"1603_CR46","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3174\/AJNR.A5572","volume":"39","author":"A Lasocki","year":"2018","unstructured":"Lasocki A, Gaillard F, Gorelik A, Gonzales M. MRI Features Can Predict 1p\/19q Status in Intracranial Gliomas. Am J Neuroradiol. 2018;39:687\u201392. https:\/\/doi.org\/10.3174\/AJNR.A5572.","journal-title":"Am J Neuroradiol"},{"key":"1603_CR47","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3174\/AJNR.A5957","volume":"40","author":"PP Batchala","year":"2019","unstructured":"Batchala PP, Muttikkal TJE, Donahue JH, et al. Neuroimaging-Based Classification Algorithm for Predicting 1p\/19q-Codeletion Status in IDH-Mutant Lower Grade Gliomas. Am J Neuroradiol. 2019;40:426\u201332. https:\/\/doi.org\/10.3174\/AJNR.A5957.","journal-title":"Am J Neuroradiol"},{"key":"1603_CR48","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.1158\/1078-0432.CCR-17-0560","volume":"23","author":"SH Patel","year":"2017","unstructured":"Patel SH, Poisson LM, Brat DJ, et al. T2\u2013FLAIR Mismatch, an Imaging Biomarker for IDH and 1p\/19q Status in Lower-grade Gliomas: A TCGA\/TCIA Project. Clin Cancer Res. 2017;23:6078\u201385. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0560.","journal-title":"Clin Cancer Res"},{"key":"1603_CR49","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/J.JOCN.2016.05.017","volume":"34","author":"I Paldor","year":"2016","unstructured":"Paldor I, Pearce FC, Drummond KJ, Kaye AH. Frontal glioblastoma multiforme may be biologically distinct from non-frontal and multilobar tumors. J Clin Neurosci. 2016;34:128\u201332. https:\/\/doi.org\/10.1016\/J.JOCN.2016.05.017.","journal-title":"J Clin Neurosci"},{"key":"1603_CR50","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.2214\/AJR.14.12636","volume":"203","author":"PA Marcovici","year":"2014","unstructured":"Marcovici PA, Taylor GA. Journal Club: Structured radiology reports are more complete and more effective than unstructured reports. AJR Am J Roentgenol. 2014;203:1265\u201371. https:\/\/doi.org\/10.2214\/AJR.14.12636.","journal-title":"AJR Am J Roentgenol"},{"key":"1603_CR51","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1148\/radiol.11101913","volume":"260","author":"LH Schwartz","year":"2011","unstructured":"Schwartz LH, Panicek DM, Berk AR, et al. Improving communication of diagnostic radiology findings through structured reporting. Radiology. 2011;260:174\u201381. https:\/\/doi.org\/10.1148\/radiol.11101913.","journal-title":"Radiology"},{"key":"1603_CR52","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/S10278-014-9703-2","volume":"27","author":"E Lin","year":"2014","unstructured":"Lin E, Powell D, Kagetsu N. Efficacy of a checklist-style structured radiology reporting template in reducing resident misses on cervical spine computed tomography examinations. J Digit Imaging. 2014;27:588\u201393. https:\/\/doi.org\/10.1007\/S10278-014-9703-2.","journal-title":"J Digit Imaging"},{"key":"1603_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/S00330-021-08327-5","author":"JM Nobel","year":"2021","unstructured":"Nobel JM, van Geel K, Robben SGF. Structured reporting in radiology: a systematic review to explore its potential. Eur Radiol. 2021. https:\/\/doi.org\/10.1007\/S00330-021-08327-5.","journal-title":"Eur Radiol"},{"key":"1603_CR54","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/J.ACRA.2017.08.005","volume":"25","author":"D Ganeshan","year":"2018","unstructured":"Ganeshan D, Duong P-AT, Probyn L, et al. Structured Reporting in Radiology. Acad Radiol. 2018;25:66\u201373. https:\/\/doi.org\/10.1016\/J.ACRA.2017.08.005.","journal-title":"Acad Radiol"},{"key":"1603_CR55","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1148\/radiol.2493080988","volume":"249","author":"DL Weiss","year":"2008","unstructured":"Weiss DL, Langlotz CP. Structured reporting: patient care enhancement or productivity nightmare? Radiology. 2008;249:739\u201347.","journal-title":"Radiology"},{"key":"1603_CR56","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jacr.2018.01.022","volume":"15","author":"BD Weinberg","year":"2018","unstructured":"Weinberg BD, Gore A, Shu HKG, et al. Management-Based Structured Reporting of Posttreatment Glioma Response With the Brain Tumor Reporting and Data System. J Am Coll Radiol. 2018;15:767\u201371. https:\/\/doi.org\/10.1016\/j.jacr.2018.01.022.","journal-title":"J Am Coll Radiol"},{"key":"1603_CR57","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"P Wen","year":"2010","unstructured":"Wen P, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010;28:1963\u201372. https:\/\/doi.org\/10.1200\/JCO.2009.26.3541.","journal-title":"J Clin Oncol"},{"key":"1603_CR58","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1007\/S00330-018-5314-5","volume":"28","author":"SC Thust","year":"2018","unstructured":"Thust SC, Heiland S, Falini A, et al. Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice. Eur Radiol. 2018;28:3306. https:\/\/doi.org\/10.1007\/S00330-018-5314-5.","journal-title":"Eur Radiol"},{"key":"1603_CR59","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.3174\/AJNR.A5794","volume":"39","author":"CC Wu","year":"2018","unstructured":"Wu CC, Jain R, Radmanesh A, et al. Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas. AJNR Am J Neuroradiol. 2018;39:1814\u201320. https:\/\/doi.org\/10.3174\/AJNR.A5794.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1603_CR60","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3174\/AJNR.A6965","volume":"42","author":"SC Thust","year":"2021","unstructured":"Thust SC, Maynard JA, Benenati M, et al. Regional and Volumetric Parameters for Diffusion-Weighted WHO Grade II and III Glioma Genotyping: A Method Comparison. AJNR Am J Neuroradiol. 2021;42:441\u20137. https:\/\/doi.org\/10.3174\/AJNR.A6965.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1603_CR61","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/S11060-016-2312-9","volume":"131","author":"H B\u00f8","year":"2017","unstructured":"B\u00f8 H, Solheim O, Jakola AS, et al. Intra-rater variability in low-grade glioma segmentation. J Neurooncol. 2017;131:393\u2013402. https:\/\/doi.org\/10.1007\/S11060-016-2312-9.","journal-title":"J Neurooncol"},{"key":"1603_CR62","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1212\/01.WNL.0000049467.54667.92","volume":"60","author":"MJ Vos","year":"2003","unstructured":"Vos MJ, Uitdehaag BMJ, Barkhof F, et al. Interobserver variability in the radiological assessment of response to chemotherapy in glioma. Neurology. 2003;60:826\u201330. https:\/\/doi.org\/10.1212\/01.WNL.0000049467.54667.92.","journal-title":"Neurology"},{"key":"1603_CR63","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1109\/TMI.2014.2377694","volume":"34","author":"BH Menze","year":"2015","unstructured":"Menze BH, Jakab A, Bauer S, et al. The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS). IEEE Trans Med Imaging. 2015;34:1993\u20132024. https:\/\/doi.org\/10.1109\/TMI.2014.2377694.","journal-title":"IEEE Trans Med Imaging"},{"key":"1603_CR64","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1109\/TMI.2016.2538465","volume":"35","author":"S Pereira","year":"2016","unstructured":"Pereira S, Pinto A, Alves V, Silva CA. Brain Tumor Segmentation Using Convolutional Neural Networks in MRI Images. IEEE Trans Med Imaging. 2016;35:1240\u201351. https:\/\/doi.org\/10.1109\/TMI.2016.2538465.","journal-title":"IEEE Trans Med Imaging"},{"key":"1603_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep23376","volume":"6","author":"R Meier","year":"2016","unstructured":"Meier R, Knecht U, Loosli T, et al. (2016) Clinical Evaluation of a Fully-automatic Segmentation Method for Longitudinal Brain Tumor Volumetry. Sci Rep. 2016;6:1\u201311. https:\/\/doi.org\/10.1038\/srep23376.","journal-title":"Sci Rep"},{"issue":"5","key":"1603_CR66","doi-asserted-by":"publisher","first-page":"e96873","DOI":"10.1371\/journal.pone.0096873","volume":"9","author":"N Porz","year":"2014","unstructured":"Porz N, Bauer S, Pica A, et al. Multi-modal glioblastoma segmentation: Man versus machine. PLoS ONE. 2014;9(5):e96873. https:\/\/doi.org\/10.1371\/journal.pone.0096873.","journal-title":"PLoS ONE"},{"key":"1603_CR67","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.3390\/CANCERS13122854","volume":"13","author":"I Kommers","year":"2021","unstructured":"Kommers I, Bouget D, Pedersen A, et al. Glioblastoma Surgery Imaging\u2014Reporting and Data System: Standardized Reporting of Tumor Volume, Location, and Resectability Based on Automated Segmentations. Cancers (Basel). 2021;13:2854. https:\/\/doi.org\/10.3390\/CANCERS13122854.","journal-title":"Cancers (Basel)"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01603-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01603-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01603-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T23:47:58Z","timestamp":1742860078000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01603-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1603"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01603-6","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was registered with the Clinical Governance Committee for the radiology department at the National Hospital of Neurology and Neurosurgery, Queen Square, London UK. It was registered as a clinical audit and therefore did not undergo further ethical approval. Informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}